Millipore Exploring Alternatives Following News of Acquisition Bid
Millipore said late last night that its board of directors is evaluating "strategic alternatives to enhance shareholder value," including a potential merger or sale of the company. Millipore's statement comes two days after Bloomberg reported that Thermo Fisher Scientific had made a $6 billion b id for the firm. Millipore confirmed that it has hired Goldman Sachs as its financial advisor and Cravath, Swaine & Moore as its legal advisor to assist the board in its evaluation. Millipore also said that it has not set a timetable for completing the evaluation and cannot assure that it will lead to any transaction. In early Wednesday trade on the New York Stock Exchange, shares of Millipore were up 3 percent at $91.50. Its shares are up 28 percent for the week.